Mycoses
News
FDA approves ibrexafungerp for vaginal yeast infection
This is the first drug in a new antifungal class.
Conference Coverage
Infective endocarditis from IV drug use tied to hemorrhagic stroke
From the Journals
Posaconazole prophylaxis was effective in children with ALL undergoing chemotherapy
Targeted posaconazole prophylaxis was effective in preventing invasive fungal infection in children with ALL undergoing induction chemotherapy.
From the Journals
ID consult for Candida bloodstream infections can reduce mortality risk
Conference Coverage
In vasculitis, the skin tells the story
MILAN – Confirmatory lab testing – and assessing for renal involvement – are still paramount, however.
Video
Onychomycosis that fails terbinafine probably isn’t T. rubrum
WAIKOLOA, HAWAII – T. rubrum remains the most common cause of toenail fungus in the United States, but...
From the Journals
Severe influenza increases risk of invasive pulmonary aspergillosis in the ICU
From the Journals
NYC outbreak of Candida auris linked to 45% mortality
Conference Coverage
So it’s pediatric onychomycosis. Now what?
In the absence of FDA-approved treatments for children an expert offers some tips.
From the Journals
Less is more: Nanotechnology enhances antifungal’s efficacy
Combining efinaconazole with nanoparticles boosted the effectiveness of antifungal medication and reduced the amount needed.
Conference Coverage
VIDEO: Device-based therapy for onychomycosis
SAN DIEGO – Treatments currently being evaluated for onychomycosis include photodynamic therapy and iontophoresis.